Status:
COMPLETED
Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine
Lead Sponsor:
Egymedicalpedia
Conditions:
Post Operative Pain
Cesarean Section Pain
Eligibility:
FEMALE
20-35 years
Phase:
PHASE1
Brief Summary
Approximately 1 in 5 women who undergo CS will experience severe acute postoperative pain. The severity of pain in the acute postoperative period is a significant predictor for the development of chro...
Detailed Description
Local wound infiltration is an attractive strategy since it is efficacious and side effects are minimal. Nowadays, there is a trend toward preferring ropivacaine over other local anesthetic agents due...
Eligibility Criteria
Inclusion
- Pregnant women aged 20-35 years
- Gestational age between 37-40 weeks
- Pregnant women undergoing elective cesarean section
- Medically free
- Singleton pregnancy
Exclusion
- Emergency cesarean section
- Diabetic
- Hypertensive
- Severe anemia
- Multiple pregnancy
- Complication during section
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05276206
Start Date
March 7 2022
End Date
April 1 2022
Last Update
July 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University
Cairo, Egypt